Closed trials
Closed Trials
QCGC Research developed the Competency Assessment Tool for Sentinel Node Biopsy (CAT-SNB). This validated tool standardizes SLND techniques and ensures surgical quality, enabling reliable clinical trial results worldwide.
Targets obese, young or co-morbid patients with early endometrial cancer and aims to treat these women less invasively through the use of the Mirena IUD which treats the cancer from inside the uterus.
Studies the effectiveness of PET scanning for ovarian cancer patients instead of CT scanning.
A surgical trial that will train gynaecological surgeons in laparoscopic hysterectomies.
A worldwide trial aiming to determine the best surgical treatment option for women experiencing early stage cervical cancer via Minimally Invasive Surgery (laparoscopic (key-hole) or robotic radical hysterectomy) vs the traditional open-radical hysterectomy approach.
Examines the treatment of endometrial cancer via a laparoscopic (key-hole) hysterectomy vs the traditional open-abdominal approach.
The primary objective of this study was to establish the time of onset, incidence, prevalence and severity of lymphoedema after gynaecological cancer treatment.
The LIgHT study examines how we can reduce the number of women who have a hysterectomy via an open abdominal approach in Australia.
The LivEs Project was to learn about the lived experience of young women diagnosed with and treated for ovarian cancer.
Getting the MOST out of follow-up: a randomised controlled trial to compare three-monthly nurse-led telephone follow-up, including monitoring serum CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic-based follow-up, following completion of first-line chemotherapy in patients with epithelial ovarian cancer.
From 2009 to 2013, 109 malnourished patients requiring surgery for suspected advanced ovarian cancer were enrolled into this clinical trial to test if early enteral feeding improved postoperative quality of life and other health measures.
A non-randomised phase 2 clinical trial examining the safety, feasibility and tolerability of radical surgery, followed by combination chemotherapy with Carboplatin and Paclitaxel, followed by radical radiotherapy to the pelvis.